Prolonged STAT1 Activation Is Associated with Interferon-γ Priming for Interleukin-1-induced Inducible Nitric-oxide Synthase Expression by Islets of Langerhans*

In this study, the ability of interferon-γ (IFN-γ) to prime rat and nonobese diabetic (NOD) mouse islets for interleukin-1 (IL-1)-stimulated expression of inducible nitric-oxide synthase (iNOS) has been examined. IL-1-induced iNOS expression by rat islets is concentration-dependent with maximal expression occurring in response to 1.0 unit/ml. Individually, neither 0.1 unit/ml IL-1 nor 150 units/ml IFN-γ stimulates iNOS expression or nitrite production by rat islets. However, a 30–60-min pulse of rat islets with IFN-γ, followed by washing to remove the cytokine and continued culture with 0.1 unit/ml IL-1 for 40 h, results in iNOS expression and nitrite production to levels similar in magnitude to the individual effects of 1.0 unit/ml IL-1. A 1-h pulse with IFN-γ primes for IL-1-induced islet degeneration that is mediated by the expression of iNOS and increased production of nitric oxide. IFN-γ also primes for IL-1-induced iNOS expression and nitrite formation by NOD mouse islets. The priming actions of IFN-γ appear to be selective for β-cells, as IFN-γ primes for IL-1-induced nitrite formation by primary β-cells and RINm5F insulinoma cells, but not primary α-cells. The priming actions of IFN-γ for IL-1-induced iNOS expression do not requirede novo protein synthesis as preincubation of RINm5F cells with cycloheximide does not inhibit iNOS mRNA accumulation under priming conditions. The priming actions of IFN-γ on IL-1-induced iNOS expression persists for extended periods of up to 7 days and are associated with persistent signal transducers and activators of transcription (STAT)-1 activation. A 30-min pulse of rat islets with IFN-γ stimulates STAT1 phosphorylation, and STAT1 remains phosphorylated for up to 7 days following IFN-γ removal. In addition, STAT1 remains nuclear for up to 7 days after IFN-γ removal. These results indicate that IFN-γ primes for IL-1-induced islet degeneration via a nitric oxide-dependent mechanism. These findings also provide evidence that the priming actions of IFN-γ for IL-1-induced iNOS expression by islets are associated with the prolonged phosphorylation and activation of STAT1.

[1]  J. Corbett,et al.  IL-1 produced and released endogenously within human islets inhibits beta cell function. , 1998, The Journal of clinical investigation.

[2]  J. Corbett,et al.  Double-stranded RNA-induced Inducible Nitric-oxide Synthase Expression and Interleukin-1 Release by Murine Macrophages Requires NF-κB Activation* , 1998, The Journal of Biological Chemistry.

[3]  J. Corbett,et al.  Potential role of resident islet macrophage activation in the initiation of autoimmune diabetes. , 1998, Journal of immunology.

[4]  C. Benoist,et al.  Interferon-gamma impacts at multiple points during the progression of autoimmune diabetes. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[5]  J. Darnell STATs and gene regulation. , 1997, Science.

[6]  J. Corbett,et al.  Interferon-γ Increases the Sensitivity of Islets of Langerhans for Inducible Nitric-oxide Synthase Expression Induced by Interleukin 1* , 1997, The Journal of Biological Chemistry.

[7]  J. Darnell,et al.  The rapid inactivation of nuclear tyrosine phosphorylated Stat1 depends upon a protein tyrosine phosphatase. , 1996, The EMBO journal.

[8]  Xiaojian Huang,et al.  Genetic Absence of γ-Interferon Delays but Does Not Prevent Diabetes in NOD Mice , 1996, Diabetes.

[9]  M. Mcdaniel,et al.  Intraislet release of interleukin 1 inhibits beta cell function by inducing beta cell expression of inducible nitric oxide synthase , 1995, The Journal of experimental medicine.

[10]  M. Mcdaniel,et al.  Tyrosine kinase involvement in IL-1 beta-induced expression of iNOS by beta-cells purified from islets of Langerhans. , 1994, The American journal of physiology.

[11]  M. Mcdaniel,et al.  Reversibility of interleukin-1 beta-induced islet destruction and dysfunction by the inhibition of nitric oxide synthase. , 1994, The Biochemical journal.

[12]  E. Unanue,et al.  Nitric oxide production in islets from nonobese diabetic mice: aminoguanidine-sensitive and -resistant stages in the immunological diabetic process. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[13]  C. Nathan,et al.  Promoter of the mouse gene encoding calcium-independent nitric oxide synthase confers inducibility by interferon gamma and bacterial lipopolysaccharide , 1993, The Journal of experimental medicine.

[14]  M. Mcdaniel,et al.  Nitric oxide mediates cytokine-induced inhibition of insulin secretion by human islets of Langerhans. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[15]  M. Mcdaniel,et al.  Interleukin 1 beta induces the formation of nitric oxide by beta-cells purified from rodent islets of Langerhans. Evidence for the beta-cell as a source and site of action of nitric oxide. , 1992, The Journal of clinical investigation.

[16]  B. Wolf,et al.  Nitric oxide and cyclic GMP formation induced by interleukin 1 beta in islets of Langerhans. Evidence for an effector role of nitric oxide in islet dysfunction. , 1992, The Biochemical journal.

[17]  N. Welsh,et al.  Interleukin-1 beta-induced nitric oxide production in isolated rat pancreatic islets requires gene transcription and may lead to inhibition of the Krebs cycle enzyme aconitase. , 1991, Endocrinology.

[18]  W. Arend Interleukin 1 receptor antagonist. A new member of the interleukin 1 family. , 1991, The Journal of clinical investigation.

[19]  P. Lacy,et al.  Activation of intraislet lymphoid cells causes destruction of islet cells. , 1991, The American journal of pathology.

[20]  P. Bedossa,et al.  Prevention of diabetes in NOD mice treated with antibody to murine IFN gamma. , 1991, Journal of autoimmunity.

[21]  L. Harrison,et al.  Essential role for interferon-gamma and interleukin-6 in autoimmune insulin-dependent diabetes in NOD/Wehi mice. , 1991, The Journal of clinical investigation.

[22]  I. Green,et al.  Inhibition of insulin secretion by interleukin‐1β and tumour necrosis factor‐α via an L‐arginine‐dependent nitric oxide generating mechanism , 1990 .

[23]  M. Mcdaniel,et al.  Interleukin 1 inhibits insulin secretion from isolated rat pancreatic islets by a process that requires gene transcription and mRNA translation. , 1990, The Journal of clinical investigation.

[24]  A. Rabinovitch,et al.  Interferon-gamma sensitizes rat pancreatic islet cells to lysis by cytokines and cytotoxic cells. , 1990, Journal of autoimmunity.

[25]  S. Galli,et al.  Interleukin 3-dependent and -independent mast cells stimulated with IgE and antigen express multiple cytokines , 1989, The Journal of experimental medicine.

[26]  N. Sarvetnick,et al.  Insulin-dependent diabetes mellitus induced in transgenic mice by ectopic expression of class II MHC and interferon-gamma , 1988, Cell.

[27]  D. Pipeleers,et al.  A new in vitro model for the study of pancreatic A and B cells. , 1985, Endocrinology.

[28]  J. Nerup,et al.  Cytokines Cause Functional and Structural Damage to Isolated Islets of Langerhans , 1985, Allergy.

[29]  P. Lacy,et al.  A subcellular fractionation approach for studying insulin release mechanisms and calcium metabolism in islets of Langerhans. , 1983, Methods in enzymology.

[30]  S. Tannenbaum,et al.  Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. , 1982, Analytical biochemistry.

[31]  J. Ono,et al.  Preparation of single cells from pancreatic islets of adult rat by the use of dispase. , 1977, Endocrinologia japonica.

[32]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.